Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurtin, P.
Right arrow Articles by Nissenson, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurtin, P.
Right arrow Articles by Nissenson, A. R.

Journal of the American Society of Nephrology, Vol 3, 1738-1747, Copyright © 1993 by American Society of Nephrology


REVIEWS

Variation in end-stage renal disease patient outcomes: what we know, what should we know, and how do we find it out?

P Kurtin and AR Nissenson

The size and expense of the ESRD program exceed all predictions made when the program was first initiated. Although the effectiveness of dialytic therapy is unquestioned, its value (quality/cost) is actively debated in this era of constricting resources. To better evaluate the quality of the ESRD program, it is essential to first define and quantitate the outcomes of dialytic care. Although mortality is a convenient outcome measure, it may be affected by many patient-specific as well as other factors that must be considered when evaluating and comparing new and existing technologies or advances. Quality of life is only beginning to be used in depth as an outcome measure, and much work is needed to standardize research methodology and thus move this area forward. The following review describes the current state of knowledge regarding outcomes of ESRD patients and proposes areas for future investigation, which should help increase the understanding of the value of the ESRD program to patients, providers, and payors.


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
A. C. Gerson, A. Riley, B. A. Fivush, N. Pham, J. Fiorenza, J. Robertson, M. Chandra, H. Trachtman, R. Weiss, S. L. Furth, et al.
Assessing Health Status and Health Care Utilization in Adolescents with Chronic Kidney Disease
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1427 - 1432.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP